Literature DB >> 1464738

Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils.

D M Smith1, M Waite.   

Abstract

We describe here and partially characterize a Ca(2+)-independent phospholipase A2 that acts on phosphatidylinositol in normal human peripheral blood neutrophils. Neutrophils incubated with myo-[3H]inositol to form [3H]phosphatidylinositol and then stimulated with the calcium ionophore A23187 produced [3H]lysophosphatidylinositol. This deacylation was further characterized in cell sonicates by the specific release of [3H]arachidonic acid from exogenous [1-14C]stearoyl-2-[3H]arachidonyl-phosphatidylinositol. This phospholipase A2 is Ca2+ independent, retaining full activity in the presence of 10 mM EDTA, and is optimally active at alkaline pH (pH 9). A phosphatidylinositol-hydrolyzing phospholipase C activity was characterized by the production of [3H]-/[14C]-diglycerides. This phospholipase C activity is dependent on the presence of exogenous Ca2+ and is optimally active at neutral pH (pH 7.5). The lipoxygenase/cyclooxygenase inhibitors eicosatetraenoic acid and nordihydroguaiaretic acid and the calmodulin antagonist trifluoperazine were the only compounds tested that showed significant inhibition of phospholipase A2 activity. However, none of these phosphatidylinositol-hydrolyzing phospholipase A2 inhibitory compounds resulted in the accumulation of any radiolabeled diglyceride, monoglyceride, or phosphatidic acid intermediates. Following subcellular fractionation on sucrose density gradients, it was found that the plasma membrane-enriched fractions contained the highest specific activity for phospholipase A2; however, the cytosolic fraction contained a large part of the total phospholipase A2 activity. Furthermore, when neutrophils were first exposed to several agents, including lipopolysaccharide, phorbol myristate acetate, or N-formyl-methionyl-leucyl- phenylalanine, and then subfractionated, there was a significant translocation of the enzyme activity from the cytosolic fraction to the membrane-enriched fractions. These data suggest that this Ca(2+)-independent, phosphatidylinositol-hydrolyzing phospholipase A2 may play an important role in early cell activation, providing free arachidonic acid for subsequent metabolism into biologically active eicosanoids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464738     DOI: 10.1002/jlb.52.6.670

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids.

Authors:  B S Robinson; C S Hii; A Poulos; A Ferrante
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Julia Kargl; Clara Andradas; Andrew J Brown; Andrew Irving; Cristina Sanchez; Maria Waldhoer
Journal:  Mol Endocrinol       Date:  2011-09-29

3.  GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.

Authors:  Nariman A B Balenga; Elma Aflaki; Julia Kargl; Wolfgang Platzer; Ralf Schröder; Stefanie Blättermann; Evi Kostenis; Andrew J Brown; Akos Heinemann; Maria Waldhoer
Journal:  Cell Res       Date:  2011-04-05       Impact factor: 25.617

4.  Measurements of phospholipases A2, C, and D (PLA2, PLC, and PLD). In vitro microassays, analysis of enzyme isoforms, and intact-cell assays.

Authors:  Julian Gomez-Cambronero; Joel Horwitz; Ramadan I Sha'afi
Journal:  Methods Mol Biol       Date:  2003

5.  Activation of phospholipase A2 in human neutrophils by polyunsaturated fatty acids and its role in stimulation of superoxide production.

Authors:  B S Robinson; C S Hii; A Ferrante
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

6.  Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.

Authors:  P P McDonald; S R McColl; P Braquet; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

7.  GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.

Authors:  J Kargl; L Andersen; C Hasenöhrl; D Feuersinger; A Stančić; A Fauland; C Magnes; A El-Heliebi; S Lax; S Uranitsch; J Haybaeck; A Heinemann; R Schicho
Journal:  Br J Pharmacol       Date:  2015-11-25       Impact factor: 8.739

8.  The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.

Authors:  Nicole A Hofmann; Jiang Yang; Sunia A Trauger; Hironao Nakayama; Lan Huang; Dirk Strunk; Marsha A Moses; Michael Klagsbrun; Joyce Bischoff; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

9.  Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.

Authors:  P K Tithof; E Schiamberg; M Peters-Golden; P E Ganey
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

10.  Role of GPR55 during Axon Growth and Target Innervation.

Authors:  Hosni Cherif; Anteneh Argaw; Bruno Cécyre; Alex Bouchard; Jonathan Gagnon; Pasha Javadi; Sébastien Desgent; Ken Mackie; Jean-François Bouchard
Journal:  eNeuro       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.